70 likes | 84 Views
Antithrombin, also known as antithrombin III (AT), is a protein that plays a crucial role in regulating blood clotting or coagulation. It is a natural anticoagulant produced in the liver and belongs to a family of proteins called serpins (serine protease inhibitors). Antithrombin inhibits several enzymes involved in the coagulation cascade, particularly thrombin (also known as factor IIa) and factors IXa, Xa, XIa, and XIIa. By inhibiting these enzymes, antithrombin helps to prevent the formation of blood clots.
E N D
Antithrombin Market
Segmentation (Scope) By Application By Source & Dosage Form • Therapeutics • Human • Goat Milk • Research • Others • Diagnostics • Lyophilized • Others • Liquid © Coherent Market Insights. All Rights Reserved
Major Drivers • Surgery and Trauma: Surgical procedures and traumatic injuries can trigger a cascade of events that promote blood clotting. • Cancer and Chemotherapy: Cancer itself, as well as certain types of chemotherapy, can increase the risk of abnormal blood clotting. © Coherent Market Insights. All Rights Reserved
NORTH AMERICA ASIA PACIFIC Market Size US$ 577.4 million Market Size US$ 849.87 million CAGR 4.3%. CAGR 4.6%. © Coherent Market Insights. All Rights Reserved
Major Players Grifols Shire BDI Pharma rEVO Biologics Green Cross Corp CSL Limited GTC Biotherapeutics KedrionS.p.A Scripps Laboratories Inc. Lee Bisolutions © Coherent Market Insights. All Rights Reserved
Global Latex Medical Disposables Market (%)Analysis, By Product Type, 2023 30% ? ? ? ? Recombinant Antithrombin Plasma-derived Antithrombin Synthetic Antithrombin Others © Coherent Market Insights. All Rights Reserved